This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Carter's (CRI) to Report Q2 Results: What to Know Ahead of the Release
by Zacks Equity Research
Carter's (CRI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Carter's (CRI) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Carter's (CRI) have what it takes? Let's find out.
Here's Why You Should Hold Carter's (CRI) Stock Right Now
by Zacks Equity Research
Despite supply-chain woes, Carter's (CRI) seems poised for further growth on the back of online strength and improved price realization. Its upbeat 2022 view raises optimism.
This is Why Carter's (CRI) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Carter's (CRI) have what it takes? Let's find out.
Carter's (CRI) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Carter's (CRI) delivered earnings and revenue surprises of 23.88% and 4.47%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Cimpress (CMPR) Q3 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Cimpress' (CMPR) third-quarter fiscal 2022 revenues gain from impressive performance across its segments.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should You Buy Carter's (CRI) Ahead of Earnings?
by Zacks Equity Research
Carter's (CRI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Here's How Carter's (CRI) Looks Just Ahead of Q1 Earnings
by Zacks Equity Research
Carter's (CRI) Q1 results are likely to reflect gains from solid demand and growth across channels and brands, offset by elevated transportation and compensation costs.
Will Carter's (CRI) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Carter's (CRI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CRI vs. NKE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CRI vs. NKE: Which Stock Is the Better Value Option?
Zacks.com featured highlights include Carter, Expro Group Holdings, and Nielsen
by Zacks Equity Research
Carter's, Expro Group Holdings, and Nielsen are part of the Screen of the Week Article.
3 Top Stocks to Invest In for Superb Earnings Acceleration
by Tirthankar Chakraborty
Invest in stocks like Carter's (CRI), Expro Group Holdings (XPRO) and Nielsen (NLSN) for now because of solid earnings acceleration.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CRI or NKE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CRI vs. NKE: Which Stock Is the Better Value Option?
Carter's (CRI) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks.com featured highlights include Carter's, AutoNation, Teck Resources, TotalEnergies and Marathon Petroleum
by Zacks Equity Research
Carter's, AutoNation, Teck Resources, TotalEnergies and Marathon Petroleum have been highlighted in this Screen of the week article.
5 PEG-Based GARP Stocks for a Winning Portfolio
by Urmimala Biswas
Here we screen five GARP stocks, CRI, AN, TECK, TTE, and MPC based on discounted PEG
The Zacks Analyst Blog Highlights Builders FirstSource, Carter's and Target
by Zacks Equity Research
Builders FirstSource, Carter's and Target have been highlighted in this Analyst Blog.
Zacks.com featured highlights include Carters, Fluor, Micron Technology, Callon Petroleum and Iron Mountain
by Zacks Equity Research
Carters, Fluor, Micron Technology, Callon Petroleum and Iron Mountain have been highlighted in this Screen of the Week article.
Capitalize On a Rebounding Market With 3 Highly Ranked Retail Stocks
by Derek Lewis
Riding on the tails of last Wednesday's meeting with the Fed, the major indices turned in their best weekly performances since last November and provided investors with a much-needed relief rally.
Invest in These 5 Stocks With Upgraded Broker Ratings
by Swayta Shah
One must follow rating upgrades by brokers as they have a deeper understanding of the stocks. So, we choose Carter's (CRI), Fluor (FLR), Micron (MU), Callon Petroleum (CPE) & Iron Mountain (IRM) as these witness ratings upgrades.
CRI vs. NKE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CRI vs. NKE: Which Stock Is the Better Value Option?
Zacks.com featured highlights include Carter's, Target Hospitality, iQIYI, The Buckle, and Corbus Pharmaceuticals
by Zacks Equity Research
Carter's, Target Hospitality, iQIYI, The Buckle, and Corbus Pharmaceuticals are part of today's Screen of the Week blog.